early versus invasive management for patients with unstable angina / NSTEMI
Last reviewed 01/2018
Early invasive versus conservative management
- coronary angiography should be offered (with follow-on PCI if indicated) within 96 hours of first admission to hospital to patients who have an intermediate or higher risk of adverse cardiovascular events (predicted 6-month mortality above 3.0%) if they have no contraindications to angiography (such as active bleeding or comorbidity). Perform angiography as soon as possible for patients who are clinically unstable or at high ischaemic risk
- conservative management without early coronary angiography should be offered to patients with a low risk of adverse cardiovascular events (predicted 6-month mortality 3.0% or less)
- coronary angiography (with follow-on PCI if indicated) should be offered to patients initially assessed to be at low risk of adverse cardiovascular events (predicted 6-month mortality 3.0% or less) if ischaemia is subsequently experienced or is demonstrated by ischaemia testing
Notes:
- as soon as the diagnosis of unstable angina or NSTEMI is made, and aspirin
and antithrombin therapy have been offered, formally assess individual risk
of future adverse cardiovascular events using an established risk scoring
system that predicts 6-month mortality (for example, Global Registry of Acute
Cardiac Events [GRACE])
- include in the formal risk assessment:
- a full clinical history (including age, previous myocardial infarction [MI] and previous percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG])
- a physical examination (including measurement of blood pressure and heart rate)
- resting 12-lead electrocardiography (ECG) (looking particularly for dynamic or unstable patterns that indicate myocardial ischaemia)
- blood tests (such as troponin I or T, creatinine, glucose and haemoglobin)
- include in the formal risk assessment:
-
Predicted 6-month mortality Risk of future adverse cardiovascular events 1.5% or below lowest > 1.5 to 3.0% low > 3.0 to 6.0% intermediate > 6.0 to 9.0% over 9.0% high over 9.0% highest
Reference:
percutaneous coronary intervention versus coronary artery bypass grafting